| Mechanism of West Nile virus neuroinvasion: a critical appraisal WW Suen, NA Prow, RA Hall, H Bielefeldt-Ohmann Viruses 6 (7), 2796-2825, 2014 | 136 | 2014 |
| Molecular determinants of virulence of West Nile virus in North America DWC Beasley, CT Davis, M Whiteman, B Granwehr, RM Kinney, ... Emergence and Control of Zoonotic Viral Encephalitides, 35-41, 2004 | 86 | 2004 |
| Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice M Venter, PJ van Vuren, J Mentoor, J Paweska, J Williams Vaccine 31 (37), 3856-3862, 2013 | 22 | 2013 |
| Pathology of fatal lineage 1 and 2 West Nile virus infections in horses in South Africa JH Williams, S Van Niekerk, S Human, E Van Wilpe, M Venter Journal of the South African Veterinary Association 85 (1), 1-13, 2014 | 15 | 2014 |
| Full-genome sequence of a neuroinvasive West Nile virus lineage 2 strain from a fatal horse infection in South Africa JLD Mentoor, AB Lubisi, T Gerdes, S Human, JH Williams, M Venter Genome announcements 4 (4), 10.1128/genomea. 00740-16, 2016 | 10 | 2016 |
| Comparative pathology of neurovirulent lineage 1 (NY99/385) and lineage 2 (SPU93/01) West Nile virus infections in BALBc mice JH Williams, JDL Mentoor, E Van Wilpe, M Venter Veterinary Pathology 52 (1), 140-151, 2015 | 10 | 2015 |
| Pathology of west nile virus lineages 1 and 2 in mice and horses JH Williams University of Pretoria, 2014 | | 2014 |
| Development of an AHSV VP7/WNV envelope domain III recombinant as a subunit vaccine candidate for protection against West Nile virus. JLD Mentoor, QC Meyer, M Venter, H Huismans | | 2010 |